Valuation : DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 20.44B 3.05B 2.62B 2.47B 2.25B 4.21B 291B 4.25B 29.44B 11.33B 148B 11.44B 11.19B 469B P/E 2026 *
13.8x
P/E 2027 * 12x
Enterprise Value 17.1B 2.55B 2.19B 2.07B 1.88B 3.52B 244B 3.55B 24.63B 9.48B 124B 9.57B 9.36B 393B EV / Sales 2026 *
0.58x
EV / Sales 2027 * 0.51x
Free-Float
34.77%
Yield 2026 *
5.25%
Yield 2027 * 5.81%
1 day-1.81%
1 week-3.03%
Current month-2.71%
1 month-1.54%
3 months+9.12%
6 months-6.95%
Current year+1.87%
1 week 17.9
Extreme 17.9
18.92
1 month 17.33
Extreme 17.33
19.23
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
27.1
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 2019-02-27
Director of Finance/CFO 44 2018-05-09
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 2013-07-15
Director/Board Member 63 2016-08-07
Chairman 48 2015-05-27
Change 5-day change 1-year change 3-year change Capi.($)
-1.81%-3.03%+3.76%-28.77% 3.05B
+0.29%-6.26%-49.51%-19.40% 14.09B
-0.62%-4.79%-21.65%-13.49% 6.36B
+0.50%-3.82%-58.06%-36.15% 6.19B
-0.61%-0.96%-11.62%-20.83% 4.1B
-1.35%-0.05%-19.53%-38.41% 3.17B
+1.91%-4.42%-46.29%-27.17% 2.81B
+1.01%+9.22%+51.24% - 2.78B
-0.66%+3.95%-15.97%-6.29% 2.52B
+2.80%+9.36%+85.08%+143.25% 1.61B
Average +0.15%+0.29%-8.25%-5.25% 4.67B
Weighted average by Cap. +0.04%-1.42%-25.37%-16.85%

Financials

2026 *2027 *
Net sales 29.54B 4.4B 3.79B 3.57B 3.25B 6.08B 421B 6.14B 42.53B 16.37B 213B 16.53B 16.17B 678B 32.52B 4.85B 4.17B 3.93B 3.58B 6.7B 463B 6.76B 46.83B 18.02B 235B 18.2B 17.8B 746B
Net income 1.49B 221M 190M 180M 164M 306M 21.17B 309M 2.14B 823M 10.74B 831M 813M 34.1B 1.71B 255M 219M 207M 188M 352M 24.38B 356M 2.46B 948M 12.36B 957M 937M 39.27B
Net Debt -3.34B -498M -428M -404M -368M -688M -47.58B -694M -4.81B -1.85B -24.13B -1.87B -1.83B -76.66B -3.76B -560M -482M -455M -414M -774M -53.57B -781M -5.41B -2.08B -27.17B -2.1B -2.06B -86.3B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
26-09-10 CN¥17.95 -1.81% 5,359,345
26-09-09 CN¥18.28 +0.22% 5,236,043
26-09-08 CN¥18.24 -0.92% 5,893,654
26-09-07 CN¥18.41 -2.02% 5,601,557
26-09-04 CN¥18.79 +1.51% 6,119,561
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
17.95CNY
Average target price
23.75CNY
Spread / Average Target
+32.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!